IQ-AI Limited’s (LON:IQAI) subsidiary Imaging Biometrics has had its new IB Rad Tech software platform installed at the Barrow Neurological Institute in St. Joseph's Hospital and Medical Center in Arizona.
The investment firm said IB’s Rad Tech software would be used to help assess treatment response options for patients with brain tumours and was chosen for its “ability to efficiently generate quantitative maps of enhancing regions of tumour (Delta T1) and fractional tumour burden (FTB)”.
READ: IQ-AI’s Imaging Biometrics appoints South Korean distributor as it receives regulatory certification
These perfusion-derived FTB maps have been shown to help clinicians in distinguishing between tumour and non-tumour tissue.
David Smith, chief executive of Imaging Biometrics, said: "Using this automated normalisation algorithm within an IB Rad Tech workflow enables objective longitudinal assessment and can help assess whether a certain treatment protocol is working for brain tumour patients”.
“Removing the variability of the manually-placed [regions of interest] is a more repeatable and faster method to do inter- and intra-study comparisons for multi-centre clinical trials as well."
The installation follows IB’s appointment of a South Korean distributor for its diagnostic imaging products in November after receiving ISO regulatory certification for its medical devices and quality management systems.